Hikma Pharmaceuticals PLC (LON:HIK - Get Free Report)'s stock price crossed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of GBX 1,928.90 ($23.47) and traded as high as GBX 2,102 ($25.57). Hikma Pharmaceuticals shares last traded at GBX 2,091.92 ($25.45), with a volume of 345,375 shares traded.
Hikma Pharmaceuticals Price Performance
The company's 50-day moving average price is GBX 1,949.17 and its 200-day moving average price is GBX 1,928.90. The company has a quick ratio of 1.27, a current ratio of 1.66 and a debt-to-equity ratio of 55.48. The firm has a market cap of £4.64 billion, a price-to-earnings ratio of 3,218.34, a PEG ratio of 2.38 and a beta of 0.41.
Hikma Pharmaceuticals Company Profile
(
Get Free Report)
At Hikma we help put better health within reach, every day. By creating high-quality medicines and making them accessible to the people who need them, we help to shape a healthier world that enriches all our communities. We help deliver this by living our culture, delivering our strategy, and acting responsibly.
Featured Stories
Before you consider Hikma Pharmaceuticals, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Hikma Pharmaceuticals wasn't on the list.
While Hikma Pharmaceuticals currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
MarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
